OneSource Specialty Pharma Limited(IN:ONESOURCE)
₹1,582.00-35.85 (-2.22%)
IN:ONESOURCE
OneSource Specialty Pharma Limited financials statements
₹1,582.00
At close:-35.85 (-2.22%)
Want to see IN:ONESOURCE full AI Analyst Report?
OneSource Specialty Pharma Limited (ONESOURCE) Ratios
0 Followers
OneSource Specialty Pharma Limited Ratios
IN:ONESOURCE's free cash flow for Q2 2025 was ₹-3.69B. For the 2025 fiscal year, IN:ONESOURCE's free cash flow was decreased by ₹-3.29B and operating cash flow was ₹-399.21M. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 0.98 | 0.99 | ― | ― |
| Quick Ratio | 0.83 | 0.68 | ― | ― |
| Cash Ratio | 0.14 | 0.07 | ― | ― |
| Solvency Ratio | 0.16 | 0.09 | ― | ― |
| Operating Cash Flow Ratio | -0.06 | -0.08 | ― | ― |
| Short-Term Operating Cash Flow Coverage | -0.12 | -0.15 | ― | ― |
| Net Current Asset Value | ₹ -5.83B | ₹ -9.53B | ― | ― |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.12 | 0.18 | ― | ― |
| Debt-to-Equity Ratio | 0.16 | 0.26 | ― | ― |
| Debt-to-Capital Ratio | 0.14 | 0.21 | ― | ― |
| Long-Term Debt-to-Capital Ratio | 0.04 | 0.09 | ― | ― |
| Financial Leverage Ratio | 1.28 | 1.41 | ― | ― |
| Debt Service Coverage Ratio | 0.58 | 0.38 | ― | ― |
| Interest Coverage Ratio | 1.24 | 0.21 | ― | ― |
| Debt to Market Cap | 0.04 | 0.08 | ― | ― |
| Interest Debt Per Share | 99.33 | 141.89 | ― | ― |
| Net Debt to EBITDA | 2.18 | 4.62 | ― | ― |
| Profitability Margins | ||||
| Gross Profit Margin | 69.89% | 32.05% | ― | ― |
| EBIT Margin | 13.19% | 1.77% | ― | ― |
| EBITDA Margin | 24.98% | 21.40% | ― | ― |
| Operating Profit Margin | 13.18% | 1.77% | ― | ― |
| Pretax Profit Margin | -4.64% | -6.47% | ― | ― |
| Net Profit Margin | -0.01% | -5.19% | ― | ― |
| Continuous Operations Profit Margin | -1.20% | -5.19% | ― | ― |
| Net Income Per EBT | 0.31% | 80.25% | ― | ― |
| EBT Per EBIT | -35.22% | -365.96% | ― | ― |
| Return on Assets (ROA) | -0.00% | -0.90% | ― | ― |
| Return on Equity (ROE) | -0.00% | -1.27% | ― | ― |
| Return on Capital Employed (ROCE) | 2.96% | 0.37% | ― | ― |
| Return on Invested Capital (ROIC) | 0.70% | 0.27% | ― | ― |
| Return on Tangible Assets | -0.00% | -2.54% | ― | ― |
| Earnings Yield | -0.00% | -0.44% | ― | ― |
| Efficiency Ratios | ||||
| Receivables Turnover | 3.23 | 2.06 | ― | ― |
| Payables Turnover | 2.48 | 2.58 | ― | ― |
| Inventory Turnover | 2.75 | 2.20 | ― | ― |
| Fixed Asset Turnover | 1.44 | 1.15 | ― | ― |
| Asset Turnover | 0.19 | 0.17 | ― | ― |
| Working Capital Turnover Ratio | -6.00 | -65.49 | ― | ― |
| Cash Conversion Cycle | 98.49 | 201.55 | ― | ― |
| Days of Sales Outstanding | 113.13 | 177.22 | ― | ― |
| Days of Inventory Outstanding | 132.62 | 165.86 | ― | ― |
| Days of Payables Outstanding | 147.26 | 141.52 | ― | ― |
| Operating Cycle | 245.74 | 343.08 | ― | ― |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -6.15 | -9.65 | ― | ― |
| Free Cash Flow Per Share | -17.75 | -59.31 | ― | ― |
| Dividend Paid and CapEx Coverage Ratio | -0.53 | -0.19 | ― | ― |
| Capital Expenditure Coverage Ratio | -0.53 | -0.19 | ― | ― |
| Operating Cash Flow Coverage Ratio | -0.07 | -0.07 | ― | ― |
| Operating Cash Flow to Sales Ratio | -0.05 | -0.08 | ― | ― |
| Free Cash Flow Yield | -1.09% | -4.03% | ― | ― |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -85298.43 | -228.63 | ― | ― |
| Price-to-Sales (P/S) Ratio | 12.45 | 11.87 | ― | ― |
| Price-to-Book (P/B) Ratio | 3.06 | 2.89 | ― | ― |
| Price-to-Free Cash Flow (P/FCF) Ratio | -91.77 | -24.83 | ― | ― |
| Price-to-Operating Cash Flow Ratio | -265.08 | -152.59 | ― | ― |
| Price-to-Earnings Growth (PEG) Ratio | 853.46 | -0.01 | ― | ― |
| Enterprise Value Multiple | 52.01 | 60.09 | ― | ― |
| Enterprise Value | 187.72B | 182.80B | ― | ― |
| EV to EBITDA | 52.01 | 60.09 | ― | ― |
| EV to Sales | 12.99 | 12.86 | ― | ― |
| EV to Free Cash Flow | -95.78 | -26.90 | ― | ― |
| EV to Operating Cash Flow | -276.66 | -165.31 | ― | ― |
| Tangible Book Value Per Share | 526.96 | 45.75 | ― | ― |
| Shareholders’ Equity Per Share | 532.66 | 508.83 | ― | ― |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.74 | 0.20 | ― | ― |
| Revenue Per Share | 130.87 | 124.05 | ― | ― |
| Net Income Per Share | -0.02 | -6.44 | ― | ― |
| Tax Burden | 0.00 | 0.80 | ― | ― |
| Interest Burden | -0.35 | -3.66 | ― | ― |
| Research & Development to Revenue | 0.00 | 0.00 | ― | ― |
| SG&A to Revenue | 0.08 | 0.30 | ― | ― |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | ― | ― |
| Income Quality | 1.00 | 1.50 | ― | ― |
Currency in INR

